Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Propylthiouracil 5 mg/mL in SyrSpend SF pH4

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2020 - Volume 24, Number 2
View All Articles in Issue

Page(s):  135

Propylthiouracil 5 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Propylthiouracil 5 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, propylthiouracil, formulation, stability, storage temperature, antithyroid agent, thryoid disorders, hyperthyroidism, thiocarbamide compound

Related Categories: EXCIPIENTS, FORMULATIONS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Propylthiouracil 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 135

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4
de Oliveira Ferreira Anderson
, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
Jul/Aug 2017
Pg. 339-346

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Propylthiouracil 5-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 67

Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 229

Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 136

Terbinafine 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 137

Topiramate 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 138

Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 133

Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2020
Pg. 134

Acetazolamide 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 130

Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 417

Stability of an Extemporaneously Compounded Propylthiouracil Suspension
Alexander Kenneth S
, Mitra Pallabi
Jan/Feb 2005
Pg. 82-86

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
Nov/Dec 2019
Pg. 487

Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Geiger Christine M
, Sorenson Bridget, Whaley Paul
Sep/Oct 2015
Pg. 420-427

Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Newton David W
Jul/Aug 2019
Pg. 281-287

Return to Top